When approved, coverage will depend on the FDA-approved indication
In this case, it's boosting glucagon, a key blood-sugar-regulating hormone
The tirzepatide dose groups and regimens were as follows: 12 mg (4 mg for weeks 0-3, 8 mg for weeks 4-7, and 12 mg for weeks 8-11), 15 mg-1 (2.5 mg for weeks 0-1, 5 mg for weeks 2-3, 10 mg for weeks 4-7, and 15 mg for weeks 8-11), and 15 mg-2 (2.5 mg for weeks 0-3, 7.5 mg for weeks 4-7, and 15 mg for weeks 8-11)
My sister recommended this clinic to me, and i had avery good experience
Water retention commonly occurs during the first few weeks, causing temporary weight gain and possible joint stiffness